Evidence map›Paper›PMID 42412262›Full record

ReviewCurrent osteoporosis reports2026

When X Does Not Mark the Spot: Autosomal Dominant and Recessive Forms of Renal Hypophosphatemic Rickets and Osteomalacia.

Carlos R Ferreira, Erik A Imel

Abstract readReview
In one paragraph

Review in Current osteoporosis reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Carlos R FerreiraUnit On Skeletal Genomics, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, 10 Center Drive, Building 10 CRC, Room 2-5142, Bethesda, MD, 20892, USA.ORCID http://orcid.org/0000-0002-2697-1046
Erik A ImelDepartments of Medicine and Pediatrics, Endocrinology, Indiana University School of Medicine, 1120 West Michigan Street, CL 380, Indianapolis, IN, 46112, USA. eimel@iu.edu.ORCID http://orcid.org/0000-0002-7284-3467

Funding

Skeletal and Metabolic Translational MedicineZIAHD009024 · NICHD · EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT · PI FERREIRA, CARLOS · 2025 to 2025
$2.5M
Intramural NIH HHS ZIA HD009024
6 · The paper itself

Abstract

purpose of reviewConditions resulting in elevated fibroblast growth factor 23 (FGF23) cause hypophosphatemic rickets and osteomalacia. The most common of these is X-linked hypophosphatemia. In this review we will broadly discuss the other less common and clinically distinct forms of renal hypophosphatemia, with a focus on the autosomal dominant and autosomal recessive types. RECENT

findingsVariants in multiple genes cause dominant (FGF23, SGK3, FGFR1), recessive (DMP1, ENPP1, FAM20C, INPPL1) or even somatic (NRAS, HRAS, GNAS, gene fusions) conditions of FGF23 excess, with important phenotypic differences. For example, in autosomal dominant hypophosphatemic rickets due to FGF23 variants, iron deficiency drives the phenotype, while ENPP1 variants cause phenotypes ranging from severe neonatal vascular calcifications to rickets or osteoporosis. Other gene abnormalities cause FGF23-independent hypophosphatemia, often involving kidney disease. Recognizing the different mechanisms and phenotypes of hypophosphatemic conditions is critical to prognosis, management and to developing more effective therapies.

Indexed as

Familial Hypophosphatemic RicketsFibroblast Growth FactorsOsteomalaciaRickets, HypophosphatemicFibroblast Growth Factor-23Genes, DominantGenes, RecessiveHumansRicketsFGF23 protein, humanFibroblast Growth Factor-23Fibroblast Growth FactorsAutosomal dominant hypophosphatemic ricketsAutosomal recessive hypophosphatemic ricketsFibroblast growth factor 23IronOsteomalacia

Identifiers

PMID42412262
PMCPMC13341720

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.